Skip to main content

Not investment advice.Read full disclaimer

Healthcare · Biotechnology

52W Range

28thpctl

Volume

0.50×avg

Market Cap

33.92MUSD

P/E Ratio

-2.6TTM

Div Yield

-ann

Continue with finqOS

Explore RenovoRx, Inc.'s financials

Income statements, balance sheets, and cash flows - annual and quarterly, going back 20+ years.

Start Free Trial→Sign In

14-day free trial · No credit card required

RenovoRx, Inc.

RNXTNASDAQ Capital Market·USD·Closed

RenovoRx, Inc.

RNXTNASDAQ·USD·Closed

$0.91

−6.59%

$0.91

−$0.06 (6.59%)

52W Range

28thpctl

Volume

0.50×avg

Mkt Cap

33.92MUSD

P/E

-2.6TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

RNXT: RenovoRx, Inc. Financial Statements & Revenue | finqOS